Does the presence of testosterone increase the risk of cancer?

Discover the truth about testosterone and its impact on cancer risk in men with this insightful article from the Healthy Man Blog. Despite the misconception that testosterone increases the risk of prostate cancer, studies have shown that testosterone therapy does not cause cancer or raise specific prostate antigen levels. In fact, low testosterone levels may actually increase the likelihood of cancer development. Learn about the crucial role of estrogen in prostate cancer and how maintaining a healthy hormone balance is essential. Explore the link between prostate cancer and elevated testosterone levels, and discover the potential benefits of testosterone therapy for men with localized prostatitis. Find out how controlling estrogen levels can help maintain a healthy lifestyle and reduce the risk of cancer. For more fascinating insights, visit the Healthy Man Blog!

The question of whether a natural or prescribed preventative approach can increase testosterone levels and cause prostate cancer is causing men to experience pain. Despite its negative impact on cancer risk, testosterone can serve as a powerful defense mechanism and the primary cause of cancer development in men.

Endogenous and exogenously prescribed testosterone products have not been shown to cause prostate cancer or raise specific prostate antigen levels, according to meta-analyzes in May 2015. A large-scale study has revealed that testosterone does not cause cancer.

Medical experts who conducted the study performed two separate analyses. In 18 studies, 5091 patients from prostate cancer and 11930 from the control group were tested for endogenous testosterones. The risk of prostate channel cancer was not linked to testosterone levels.

The data from 24 men who received testosterone therapy during the control study were analyzed in the second analysis. Experts emphasized that testosterone therapy does not have a positive impact on cancer risk and blood plasma levels.

As testosterone levels paradoxically increase, the risk of cancer is more likely to occur as a man’s testosterone level decreases. Having low testosterone levels is indicative of an overactive state.

Can estrogen be linked to the development of prostate cancer?

Being responsible for the development of cancer, estrogen holds significant importance. Experts have determined that the presence of testosterone and estrogen hormones is crucial for prostate cancer, based on their experience with rats. While the study in men had mixed results, some studies have shown that estrogen levels (16 and chronic elevated) increase the risk of cancer, while others show inverse correlation.

Men’s hormone levels are known to be balanced by testosterone and estrogen. The conversion of testosterone to estrogen can be facilitated by the aromatase enzyme, making it essential to adhere to the habit that reduces its activity in the body. The requirements consist of maintaining a healthy weight, reducing stomach fat, eliminating fat deposits (since it stimulates estrogen production), and restricting or eliminating alcohol (because alcohol affects testosterone), as well as maintaining good blood sugar levels.

Can prostate cancer lead to elevated testosterone levels?

It is still not established if we discuss the evidence that men with higher testosterone levels have better protection. The European Center for Urology’s report states that men who have received testosterone after localized prostatitis do not show any relapses and their symptoms are low. Without treatment for prostate cancer, some men did not experience any disease progression after undergoing testosterone therapy.

A research study carried out in November 2015 involved 98 men with hypogonadism who underwent testosterone therapy following radiation treatment for prostate cancer. testosterone therapy allowed for an increase in testosterone from its average level of 209 g/d to 420 106 l/j. Simultaneously, there was a slight surge in the PSA level.

According to recent studies, and based on research and evidence from other sources, we can conclude that doughotropin does not cause prostate cancer and has adverse effects in men who already have this condition. The development of the disease is believed to be primarily influenced by an additional estrogen. Men with elevated estrogen levels experience symptoms such as reduced libido, abnormal growth of the mammary glands and increased risk of heart attacks/heart attacks for men. They also exhibit infertility and weight gain, which are comparable to low-level testosterone levels. Controlling estrogeen is crucial for maintaining a healthy lifestyle without cancer.